www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Global EditionASIA 中文雙語(yǔ)Fran?ais
World
Home / World / Asia-Pacific

Chinese COVID-19 vaccine set for human trials in Australia

Xinhua | Updated: 2020-04-28 14:41
Share
Share - WeChat
Small bottles labbeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. [Photo/Agencies]

SYDNEY - An Australian research clinic revealed on Tuesday it will seek volunteers to trial a COVID-19 vaccine developed by China-based global biotechnology company, Clover Biopharmaceuticals.

Linear Clinical Research which is based in Perth, Western Australia, said that it will be recruiting healthy adults for the trial within the next two months.

Chief Executive Jayden Rogers said the S-Trimer vaccine on trial showed great potential and was at the forefront of the global battle with COVID-19.

"This is one of the most prominent trials globally and involves some of the most renowned vaccines companies," Rogers said.

"Combined with extensive preclinical research and commercial-scale manufacturing capabilities, COVID-19 S-Trimer is one of the most exciting vaccine programs globally for the current coronavirus pandemic."

Clover's S-Trimer vaccine is among the first COVID-19 vaccines in development. It aims to help the body produce antibodies to fight the deadly coronavirus which causes COVID-19 disease.

Phase one of the clinical trial involves healthy adult and elderly participants from Australia, which has been chosen to stage the study partially due to it's relatively low infection rates.

"We are fortunate to be one of the few countries in the world to still be offering functional clinical trial facilities because we do not have large volumes of COVID-19 cases as compared to other parts of the world," Rogers explained.

If tests in Australia are successful, the trial will be expanded to include thousands more participants worldwide, and according to the company, the vaccine will be widely available upon confirmation of its safety and efficacy.

Joshua Liang, Chief Strategy Officer at Clover Biopharmaceuticals and co-inventor of the COVID-19 S-Trimer vaccine said that given the impacts of COVID-19, a successful clinical trial is of the utmost importance to the world.

"We have been working tirelessly and hope to contribute significantly to global efforts in fighting this pandemic that has affected us all," Liang said.

In developing the vaccine, Clover scientists also expanded their collaboration to include innovations from GlaxoSmithKline (GSK UK), Dynavax (US) and Coalition for Epidemic Preparedness Innovations (CEPI Switzerland).

"The fight against COVID-19 requires a global effort bringing together the best science and innovation," Rogers said.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 成年午夜性爽快免费视频不卡 | 一级特黄a免费大片 | 91亚洲精品国产第一区 | 欧美日韩视频一区二区 | 18性欧美69| 久久在线观看免费视频 | 欧美性色一级在线观看 | 国产高清免费不卡观看 | 久热免费在线观看 | 亚洲区一区 | 日韩亚洲成a人片在线观看 日韩亚洲精品不卡在线 | 中文字幕一区二区三区免费视频 | 99视频免费在线 | 欧美日韩一区二区三区免费不卡 | 情侣偷偷看的羞羞视频网站 | 国产成人综合精品一区 | 亚洲大片免费观看 | 99久久精品费精品国产一区二区 | 久久久久毛片免费观看 | 欧美一a级做爰 | 日韩成人一级 | 国产菲菲视频在线观看 | 国产aaa女人十八毛片 | 久久久久久久久久久视频国内精品视频 | 日本在线视频不卡 | 国产三级毛片视频 | 亚洲一区二区三区四区 | 国产99视频精品一区 | 国产一区二区三区欧美 | 九九精品视频在线观看九九 | 精品国产欧美一区二区三区成人 | 久久er国产精品免费观看1 | 成人毛片免费观看视频大全 | 在线色网址 | 欧美一级片免费 | 国产乱纶 | 97在线观看视频免费 | 欧美成人高清 | 怡红院免费全部视频在线 | 亚洲高清一区二区三区四区 | 国产精品久久久久免费视频 |